1. Home
  2. CRWS vs NEUP Comparison

CRWS vs NEUP Comparison

Compare CRWS & NEUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crown Crafts Inc

CRWS

Crown Crafts Inc

HOLD

Current Price

$2.73

Market Cap

28.6M

ML Signal

HOLD

NEUP

Neuphoria Therapeutics Inc.

HOLD

Current Price

$4.58

Market Cap

23.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRWS
NEUP
Founded
1957
1996
Country
United States
United States
Employees
N/A
8
Industry
Textiles
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
28.6M
23.0M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
CRWS
NEUP
Price
$2.73
$4.58
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$21.00
AVG Volume (30 Days)
24.9K
54.3K
Earning Date
02-11-2026
02-17-2026
Dividend Yield
12.07%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$70,270,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.51
N/A
52 Week Low
$2.35
$3.65
52 Week High
$3.88
$21.31

Technical Indicators

Market Signals
Indicator
CRWS
NEUP
Relative Strength Index (RSI) 40.86 55.35
Support Level $2.54 $3.92
Resistance Level $2.94 $5.06
Average True Range (ATR) 0.09 0.25
MACD -0.02 -0.02
Stochastic Oscillator 26.58 42.80

Price Performance

Historical Comparison
CRWS
NEUP

About CRWS Crown Crafts Inc

Crown Crafts Inc operates in the infant and toddler products segment of the consumer products industry through its wholly-owned subsidiaries. The infant and toddler products segment consists of infant and toddler bedding, bibs, soft bath products, disposable products, and accessories. The company serves a diverse range of customers including mass merchants, mid-tier retailers, juvenile specialty stores, value channel stores, grocery and drug stores, restaurants, internet accounts, wholesale clubs, and internet-based retailers. The company's brands include NoJo, Neat Solutions, Sassy, and Carousel. Its products are marketed under a variety of company-owned trademarks, under trademarks licensed from others, and as private-label goods.

About NEUP Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder. The Company operates through a single operating and reportable segment focused on the discovery and development of allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need.

Share on Social Networks: